Bortezomib
NDC 51817-586, bortezomib, injection, powder, lyophilized, for solution, from Pharmascience Inc..
- Product NDC
- 51817-586
- Status
- Listed
- Labeler
- Pharmascience Inc.
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS, SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208392
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51817-586 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BORTEZOMIB3.5 mg/1
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51817-586-01 | 51817058601 | 1 VIAL in 1 CARTON (51817-586-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/191d231a-1fbd-4a65-9d33-d5dc03bac381
Use it
Look up 51817-586 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51817-586 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51817-586. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.